NASDAQ:HYAC Haymaker Acquisition Corp. III Stock Forecast, Price & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Haymaker Acquisition Corp. III Please log in to your account or sign up in order to add this asset to your watchlist. Add Compare Share Today's Range N/A50-Day Range$9.02▼$10.0652-Week Range N/AVolume28,700 shsAverage Volume116,789 shsMarket Capitalization$357.91 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Receive HYAC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Haymaker Acquisition Corp. III and its competitors with MarketBeat's FREE daily newsletter. Email Address HYAC Stock Forecast (MarketRank)Overall MarketRank™1.02 out of 5 starsMedical Sector1255th out of 1,429 stocksMedicinals & Botanicals Industry18th out of 23 stocksAnalyst Opinion: 0.0Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 - 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Haymaker Acquisition Corp. III. Previous Next 4.3 Community Rank Outperform VotesHaymaker Acquisition Corp. III has received 33 “outperform” votes. (Add your “outperform” vote.)Underperform VotesHaymaker Acquisition Corp. III has received 18 “underperform” votes. (Add your “underperform” vote.)Community SentimentHaymaker Acquisition Corp. III has received 64.71% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Haymaker Acquisition Corp. III and other stocks. Vote “Outperform” if you believe HYAC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe HYAC will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldHaymaker Acquisition Corp. III does not currently pay a dividend.Dividend GrowthHaymaker Acquisition Corp. III does not have a long track record of dividend growth. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Haymaker Acquisition Corp. III insiders have not sold or bought any company stock.Percentage Held by Institutions58.51% of the stock of Haymaker Acquisition Corp. III is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.0 Earnings and Valuation Previous Next See Top Rated MarketRank™ Stocks Here About Haymaker Acquisition Corp. III (NASDAQ:HYAC)Haymaker Acquisition Corp. III does not have any significant operations. It intends to acquire and operate a business in the consumer and consumer-related products. The company was incorporated in 2020 and is based in New York, New York.Read More HYAC Stock News HeadlinesJune 18, 2022 | americanbankingnews.comHead to Head Analysis: Haymaker Acquisition Corp. III (NASDAQ:HYAC) & ChromaDex (NASDAQ:CDXC)June 9, 2022 | americanbankingnews.comHead-To-Head Review: MediWound (NASDAQ:MDWD) vs. Haymaker Acquisition Corp. III (NASDAQ:HYAC)May 26, 2022 | finance.yahoo.comBiote Debuts as Publicly Traded Company Focused on Transforming Hormone Optimization IndustryMay 17, 2022 | finance.yahoo.comHaymaker Acquisition Corporation III Reminds Shareholders to Vote in Favor of the Proposed Business Combination with Biote Before May 24May 11, 2022 | finance.yahoo.comBiote Reports First Quarter 2022 Financial Results and Provides Corporate UpdateMarch 24, 2022 | benzinga.comHaymaker Acquisition Corp. III Combination Partner Biote Q4 Sales $37.5M, Up 22% YoYMarch 22, 2022 | finance.yahoo.comBiote Reports Record Fourth Quarter and Full Year 2021 Financial Results and Provides 2022 OutlookDecember 18, 2021 | uk.finance.yahoo.comHaymaker Acquisition Corp. III (HYAC)December 13, 2021 | benzinga.comBiote Issues PR Confirming Co. Will Be Listed On Nasdaq Through A Business Combination With Haymaker Acquisition Corp. IIIDecember 13, 2021 | thestreet.comSPAC Merger Monday sees 5 New Deals Announced, YAC gets 92% RedemptionsDecember 13, 2021 | finance.yahoo.comBiote to be Listed on Nasdaq through a Business Combination with Haymaker Acquisition Corp. IIIDecember 13, 2021 | finance.yahoo.comIrving's Biote going public through merger with SPACDecember 13, 2021 | finance.yahoo.comHormone Therapy Firm Biote Said to Go Public Via Haymaker SPACSee More Headlines Industry, Sector and Symbol Stock ExchangeNASDAQ Industry Medicinals & botanicals Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:HYAC CUSIPN/A CIK1819253 Webhaymakeracquisition.com Phone212-616-9600Fax212-616-9601Employees4Year FoundedN/ACompany Calendar Today7/01/2022Fiscal Year End12/31/2022Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$11.11 million Net MarginsN/A Pretax MarginN/A Return on Equity-130.43% Return on Assets3.49% Debt Debt-to-Equity RatioN/A Current Ratio0.20 Quick Ratio0.20 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash Flow34.92 Book Value($0.57) per share Price / BookN/AMiscellaneous Outstanding Shares39,680,000Free FloatN/AMarket Cap$357.91 million OptionableNot Optionable BetaN/A Haymaker Acquisition Corp. III Frequently Asked Questions What guidance has Haymaker Acquisition Corp. III issued on next quarter's earnings? Haymaker Acquisition Corp. III issued an update on its FY 2022 earnings guidance on Wednesday, June, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $160.00 million-$166.00 million. Who are Haymaker Acquisition Corp. III's key executives? Haymaker Acquisition Corp. III's management team includes the following people: Mr. Steven J. Heyer, Exec. Chairman & CEO (Age 69)Mr. Andrew Robert Heyer, Pres & Director (Age 64)Mr. Christopher Bradley, CFO & Sec. (Age 44)Mr. Joseph M. Tonnos, Sr. VP (Age 34)Mr. Brian Shimko, Sr. VP (Age 36) Who are some of Haymaker Acquisition Corp. III's key competitors? Some companies that are related to Haymaker Acquisition Corp. III include USANA Health Sciences (USNA), Canopy Growth (CGC), Cronos Group (CRON), Cresco Labs (CRLBF), Sundial Growers (SNDL), Canopy Rivers (RIV), True Drinks (TRUU), Bright Green (BGXX), Ayr Wellness (AYRWF), Ascend Wellness (AAWH), Aurora Cannabis (ACB), Mind Medicine (MindMed) (MNMD), biote (BTMD), MariMed (MRMD) and Exactus (EXDI). View all of HYAC's competitors. What other stocks do shareholders of Haymaker Acquisition Corp. III own? Based on aggregate information from My MarketBeat watchlists, some companies that other Haymaker Acquisition Corp. III investors own include Algonquin Power & Utilities (AQN), BCE (BCE), Franklin Resources (BEN), British American Tobacco (BTI), Carnival Co. & (CCL), Canadian Imperial Bank of Commerce (CM), Cinemark (CNK), Canadian Natural Resources (CNQ), Dominion Energy (D) and Brinker International (EAT). What is Haymaker Acquisition Corp. III's stock symbol? Haymaker Acquisition Corp. III trades on the NASDAQ under the ticker symbol "HYAC." How much money does Haymaker Acquisition Corp. III make? Haymaker Acquisition Corp. III (NASDAQ:HYAC) has a market capitalization of $0.00. How many employees does Haymaker Acquisition Corp. III have? Haymaker Acquisition Corp. III employs 4 workers across the globe. How can I contact Haymaker Acquisition Corp. III? Haymaker Acquisition Corp. III's mailing address is 650 5TH AVENUE FLOOR 10, NEW YORK NY, 10019. The official website for Haymaker Acquisition Corp. III is haymakeracquisition.com. The company can be reached via phone at 212-616-9600 or via fax at 212-616-9601. This page (NASDAQ:HYAC) was last updated on 7/1/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here
